Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes. [electronic resource]
Producer: 20170717Description: 1581-7 p. digitalISSN:- 1468-201X
- Adult
- Aged
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Cardiovascular Diseases -- diagnosis
- Cause of Death
- Databases, Factual
- Diabetes Mellitus, Type 2 -- complications
- Drug Therapy, Combination
- Female
- Glucagon-Like Peptide 1 -- adverse effects
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin -- adverse effects
- Kaplan-Meier Estimate
- Male
- Metformin -- therapeutic use
- Middle Aged
- Obesity -- complications
- Propensity Score
- Proportional Hazards Models
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sulfonylurea Compounds -- therapeutic use
- Time Factors
- Treatment Outcome
- United Kingdom
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.